| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
DRUG sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 950.0K | $85.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Cormorant Asset Management, LP49 | Former 10% Owner | Sell | 109,331 | $89.50 | $9,785,124.50 | -10.3% | -19.2% | - | |
| Nov 4, 2024 | Cormorant Asset Management, LP49 | - | Buy | 184,331 | $21.70 | $3,999,982.70 | +21.1% | -26.4% | +1.4% | |
| Oct 16, 2024 | Cormorant Asset Management, LP49 | - | Buy | 422,591 | $7.65 | $3,234,386.83 | +93.4% | +22.4% | +130.6% |